Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium
This document in this compendium was contributed by the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium which is part of the Rare Diseases Clinical Research Network (RDCRN; https://www.rarediseasesnetwork.org/). RDCRN is focused on therapeutic developments for amyotrophic lateral sclerosis, frontotemporal dementia, primary lateral sclerosis, hereditary spastic paraplegia, and progressive muscular atrophy. This SOP is available from https://www.rarediseasesnetwork.org/cms/create/researchers/biorepository.
Download all SOP documents of selected versions